S. H. YULIANI, “NANOPARTICLE AS THE STRATEGY FOR THE DEVELOPMENT OF SARS-COV-2 ANTIVIRAL DRUGS”, Int J App Pharm, vol. 13, no. 5, pp. 33–43, Sep. 2021.